BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

967 related articles for article (PubMed ID: 12353185)

  • 1. Genital shedding of herpes simplex virus among men.
    Wald A; Zeh J; Selke S; Warren T; Ashley R; Corey L
    J Infect Dis; 2002 Oct; 186 Suppl 1():S34-9. PubMed ID: 12353185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.
    Wald A; Zeh J; Selke S; Warren T; Ryncarz AJ; Ashley R; Krieger JN; Corey L
    N Engl J Med; 2000 Mar; 342(12):844-50. PubMed ID: 10727588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors.
    Krone MR; Wald A; Tabet SR; Paradise M; Corey L; Celum CL
    Clin Infect Dis; 2000 Feb; 30(2):261-7. PubMed ID: 10671325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virologic characteristics of subclinical and symptomatic genital herpes infections.
    Wald A; Zeh J; Selke S; Ashley RL; Corey L
    N Engl J Med; 1995 Sep; 333(12):770-5. PubMed ID: 7643884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men.
    Kim HN; Meier A; Huang ML; Kuntz S; Selke S; Celum C; Corey L; Wald A
    J Infect Dis; 2006 Aug; 194(4):420-7. PubMed ID: 16845624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virological, serological and epidemiological study of 255 consecutive cases of genital herpes in a sexually transmitted disease clinic of Paris (France): a prospective study.
    Janier M; Scieux C; Méouchi R; Tournoux C; Porcher R; Maillard A; Fouéré S; Taquin Y; Lassau F; Morel P
    Int J STD AIDS; 2006 Jan; 17(1):44-9. PubMed ID: 16409679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
    J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of PCR with virus isolation and direct antigen detection for diagnosis and typing of genital herpes.
    Slomka MJ; Emery L; Munday PE; Moulsdale M; Brown DW
    J Med Virol; 1998 Jun; 55(2):177-83. PubMed ID: 9598940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of herpes simplex virus-2 infection among women seeking medical care for signs and symptoms of vaginitis.
    Ross SE; Carter B; Lambert S
    Herpes; 2009 Jan; 15(3):46-50. PubMed ID: 19306602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
    Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of genital herpes infections.
    Mertz GJ
    Infect Dis Clin North Am; 1993 Dec; 7(4):825-39. PubMed ID: 8106731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acquisition of herpes simplex virus during pregnancy.
    Brown ZA; Selke S; Zeh J; Kopelman J; Maslow A; Ashley RL; Watts DH; Berry S; Herd M; Corey L
    N Engl J Med; 1997 Aug; 337(8):509-15. PubMed ID: 9262493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada.
    Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I
    Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSV shedding.
    Sacks SL; Griffiths PD; Corey L; Cohen C; Cunningham A; Dusheiko GM; Self S; Spruance S; Stanberry LR; Wald A; Whitley RJ
    Antiviral Res; 2004 Aug; 63 Suppl 1():S19-26. PubMed ID: 15450382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization.
    Cherpes TL; Melan MA; Kant JA; Cosentino LA; Meyn LA; Hillier SL
    Clin Infect Dis; 2005 May; 40(10):1422-8. PubMed ID: 15844064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected high prevalence of herpes simplex virus (HSV) type 2 seropositivity and HSV genital shedding in pregnant women living in an East Paris suburban area.
    LeGoff J; Saussereau E; Boulanger MC; Chemin C; Si-Mohamed A; Bélec L; Maisonneuve L
    Int J STD AIDS; 2007 Sep; 18(9):593-5. PubMed ID: 17785000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Herpes simplex virus type 1 and 2 in Switzerland].
    Laubereau B; Zwahlen M; Neuenschwander B; Heininger U; Schaad UB; Desgrandchamps D
    Schweiz Med Wochenschr; 2000 Feb; 130(5):143-50. PubMed ID: 10701231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors for infection with herpes simplex virus type-1 and -2 among lesbians.
    Marrazzo JM; Stine K; Wald A
    Sex Transm Dis; 2003 Dec; 30(12):890-5. PubMed ID: 14646636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations.
    Ameli N; Bacchetti P; Morrow RA; Hessol NA; Wilkin T; Young M; Cohen M; Minkoff H; Gange SJ; Greenblatt RM
    AIDS; 2006 Apr; 20(7):1051-8. PubMed ID: 16603858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.